BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Sep 21, 2017
Targets & Mechanisms

Appetite for GFRAL

Why pharmas think GFRAL could be the next obesity target
BioCentury | Mar 7, 2016
Analyst Picks & Changes

Analyst picks & changes

BioCentury | Sep 14, 2015
Finance

Gaining leverage

Reading the tea leaves of Icahn's Vivus debt play
BioCentury | Aug 10, 2015
Company News

Vivus endocrine/metabolic news

BioCentury | Aug 1, 2015
Company News

Vivus to cut Qsymia sales force

BioCentury | Apr 23, 2015
Company News

Novo launches Saxenda in the U.S.

BioCentury | Apr 6, 2015
Company News

Vivus endocrine/metabolic news

BioCentury | Dec 24, 2014
Company News

Novo's Saxenda wins FDA approval

Items per page:
1 - 10 of 278